Improving patient access to biomarker-targeted cancer trials
Official title: Overcoming Challenges Posed by Biomarker-Selective Clinical Trials: The Role of a Research Specialist
Funded at Johns Hopkins University · NIH-11044145 · Data updated 2026-11-12
This study is working to make it easier for cancer patients, especially those from minority and underserved groups, to find and join clinical trials that match their specific needs, by using a special registry and helping doctors identify eligible patients while also teaching everyone about the importance of biomarkers in their treatment.
Quick facts
| Grant type | NIH-funded research |
|---|---|
| Study type | NIH-funded research |
| Funding institution | Johns Hopkins University NIH-funded |
| Lab location | 1 site (Baltimore, United States) |
| Project start | March 1, 2023 |
| Project end | February 29, 2028 |
| Funding year | 2025 |
| Award (this year) | $105,619 |
| NIH project number | 5R50CA275932-03 |
| Project ID | NIH-11044145 on NIH RePORTER |
Who could benefit from this research
✓Could help
Ideal candidates for this research include cancer patients who may benefit from biomarker-targeted therapies and those who are part of minority or underserved populations.
✕Less likely to help
Patients who do not have cancer or those whose conditions do not involve biomarker-targeted therapies may not benefit from this research.
What this research studies
This research aims to enhance the identification and enrollment of patients in biomarker-selective clinical trials, which are crucial for advancing cancer treatment. It focuses on creating a molecular registry to streamline patient eligibility determination and using electronic medical records to alert physicians about eligible patients. Additionally, the project emphasizes educating patients about the importance of biomarkers in their treatment options, particularly targeting minority and underserved populations who may face barriers to participation.
Why it matters
Potential benefit: If successful, this research could lead to improved access to cutting-edge cancer therapies for patients, particularly those from underserved communities.
How similar studies have gone: Previous research has shown success in improving clinical trial enrollment through similar approaches, particularly in enhancing access for underrepresented populations.
Where this research is happening
-
Johns Hopkins University
Baltimore, United States Active
Researchers
- Principal investigator: Gaillard, Stephanie — Johns Hopkins University
- Study coordinator: Gaillard, Stephanie
Related research
Other NIH-funded projects on the same topics.
-
Targeting hidden brain injuries in iTTP to improve long-term brain health
A researcher aims to find out how silent brain injuries in people with immune thrombotic thrombocytopenic purpura (iTTP) happen, how they affect thinking and stroke risk, and how to prevent them.
-
Accelerated flap coverage for severe leg injuries: earlier reconstruction vs standard timing
This study tests whether doing early flap coverage after a severe leg injury lowers infection risk and improves healing for patients with open wounds and bone injury.
-
Placebo-controlled shunting for iNPH: does the surgery help with walking and balance?
A doctor-led trial at Johns Hopkins will test whether a shunt surgery improves walking and balance in older adults with idiopathic normal pressure hydrocephalus.
-
Omalizumab for COPD patients with allergen sensitization and exposure
A multicenter trial will test whether adding omalizumab helps people with COPD who are allergic to common indoor allergens and are exposed to them.
-
Johns Hopkins Total Worker Health Center focusing on mental health
A nationwide center at Johns Hopkins is working to improve mental health and well-being among workers by studying workplace health strategies and translating findings into practical tools.
-
Role of fat droplets in liver fat and inflammatory signals in NAFLD
A study at Johns Hopkins will explore how fat droplets in the liver influence molecules that drive inflammation and progression of non-alcoholic fatty liver disease (NAFLD) in adults.
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page.